Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexamethasone Plus Salvage Chemotherapy Versus Salvage Chemotherapy Alone in Patients With First Relapsed or Refractory Acute Myeloid Leukemia: a Randomized, Controlled, Open-label, Multicenter, Phase III Study

NCT03765541 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03765541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03765541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexamethasone Plus Salvage Chemotherapy Versus Salvage Chemotherapy Alone in Patients With First Relapsed or Refractory Acute Myeloid Leukemia: a Randomized, Controlled, Open-label, Multicenter, Phase III Study
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Terminated
Start date
January 13, 2020
Completion date
May 31, 2024
Enrollment
73 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed or refractory acute myeloid leukemia